U.S. Gas Utilities Stock News

Peoples Bancorp (PEBO) is back on investors’ radar after a clear pickup in institutional ownership and renewed focus on its valuation, financial health, and trading momentum within the regional banking sector. See our latest analysis for Peoples Bancorp. The recent institution led interest comes on top of firm price momentum, with a 1 day share price return of 1.40% and a 90 day share price return of 13.22%. The 1 year total shareholder return of 31.89% points to gains that go beyond short...

Churchill Downs Incorporated previously announced that the State of Maryland would exercise its rights to acquire the intellectual property, including all trademarks and associated rights, for the Preakness Stakes and Black-Eyed Susan Stakes by matching Churchill Downs’ earlier purchase agreement. This shift means Churchill Downs loses direct ownership of two prestigious race brands while remaining operationally involved at Pimlico, potentially altering how it leverages marquee events within...

Earlier in June 2026, LGI Homes, Inc. replaced Ernst & Young LLP with Deloitte & Touche LLP as its independent auditor for the 2026 fiscal year after a competitive review. At the same time, institutional ownership has climbed to a very high level, suggesting large investors are increasingly engaged despite weaker recent financial metrics. Now we’ll explore how rising institutional ownership and the new Deloitte appointment could influence LGI Homes’ existing investment narrative. The future...

EZCORP (EZPW) is back in focus after reporting quarterly results, with revenue and earnings per share well above the prior year, supported by record pawn loan activity, firm core pawn demand, and elevated gold prices. See our latest analysis for EZCORP. EZCORP’s latest results come after a period of strong market interest, with the share price up 22.38% over 90 days and a 58.13% year to date share price return. The 1 year total shareholder return of 139.40% and 5 year total shareholder return...

Dividend affirmation and earnings catalyst put Abbott Laboratories stock in focus Recent commentary on Abbott Laboratories (ABT) has centered on upcoming earnings and Citi highlighting the value of its diversified healthcare businesses, setting the stage for closer attention to the stock. The reaffirmed quarterly dividend and the approaching July 16 earnings report give investors timely reference points as they weigh Abbott Laboratories stock, its current business mix, and expectations around...

Coupang recently received a record privacy penalty of about ₩624.7B (roughly US$410.00M) from Korea’s data regulator for data breaches and unauthorized marketing-related data collection, a charge the company has paid while pursuing judicial review. Beyond the regulatory setback, Coupang has continued to report strong operating performance, including AI-enabled logistics gains, Taiwan expansion, and enhanced cross-border commerce, which together have meaningfully improved its standing on the...

Garrett Motion Stock Performance Snapshot Garrett Motion (GTX) has attracted attention after recent trading, with the stock closing at $34.32 and showing double digit total returns over the past year and past 3 months. For investors tracking performance, the company reports annual revenue of $3,691.0 and net income of $343.0, with both revenue and net income growth reported on an annual basis. See our latest analysis for Garrett Motion. Garrett Motion's recent 1-day and 7-day share price...

T. Rowe Price Group recently expanded its Capital Appreciation suite with the launch of the T. Rowe Price Capital Appreciation Market Opportunities ETF (TPUT), a fully transparent put-write ETF with a 0.25% expense ratio that began trading on NYSE Arca and is managed by a seven-person team including long-time portfolio manager David Giroux. Alongside May net inflows of US$3.30 billion on total assets under management of US$1.89 trillion and its role as an anchor client for Intercontinental...

Conexeu Sciences (CNXU) has drawn fresh attention after expanding its board and executive team, including naming co founder David Bogart as Chief Commercial Officer, as it moves its CXU wound care platform toward FDA 510(k) preparation. See our latest analysis for Conexeu Sciences. Recent appointments around the CXU platform come after a period of mixed trading, with a 7 day share price return of 17.63% and a 30 day share price return that declined 7.78% from a latest close of $13.28. This...

Recently, Ameren reaffirmed its full-year 2026 earnings guidance and emphasized continued growth driven by regulated investments across its electric and natural gas infrastructure, supported by rising demand from large-load customers such as data centers. This shift toward earnings underpinned by long-term, regulated infrastructure projects highlights Ameren’s potential to be viewed as more than a typical income-focused utility. Next, we’ll examine how Ameren’s reaffirmed earnings guidance...

Recent headlines around Acadia Healthcare Company (ACHC) focus on its facility expansion and new partnerships as demand for behavioral health services grows. This has drawn investor attention to how this capacity buildout could influence future earnings power. See our latest analysis for Acadia Healthcare Company. The recent facility expansion story comes alongside a strong recovery in Acadia Healthcare Company’s share price, with a 1-day share price return of 5.83%, a 30-day share price...

A10 Networks (ATEN) is back in focus after quarterly results topped revenue and earnings expectations, and the company agreed to acquire AI security firm TrojAI, a combination that has drawn fresh investor attention. See our latest analysis for A10 Networks. The recent earnings beat and the TrojAI deal come on top of strong share price momentum, with A10 Networks posting a 14.06% 1 month share price return and a 91.70% year to date share price return, alongside a 5 year total shareholder...

Pagaya Technologies (NasdaqCM:PGY) is back in focus after closing an upsized, AAA-rated US$800 million personal loan ABS deal and expanding its partnership with Upgrade’s Flex Pay Buy Now, Pay Later platform. See our latest analysis for Pagaya Technologies. Those ABS and BNPL partnership headlines come against a mixed backdrop for Pagaya Technologies, with the share price up 19.42% over 30 days and 46.80% over 90 days, but the year to date share price return down 29.89% and the 1 year total...

Earlier this month, Walker & Dunlop filed foreclosure lawsuits alleging that Chicago multifamily investor Chaim Bialostozky used same‑day, back‑to‑back property sales to misrepresent values and secure inflated Freddie Mac loans, later leaving the buildings to deteriorate and defaulting on at least US$7.10 million of debt and legal costs. The cases highlight how loan quality, counterparty behavior, and the potential use of court‑appointed receivers can affect Walker & Dunlop’s risk management...

Archrock (AROC) is back on your radar after a 4.2% share price move to $36.97, amid rising attention around demand for its natural gas compression services and questions about current valuation. See our latest analysis for Archrock. Looking beyond today’s move, Archrock’s share price return is up 38.83% year to date, while its 1 year total shareholder return of 52.80% and very large 5 year total shareholder return suggest momentum has been strong as investors reassess growth potential and...

Tempus AI, Inc. recently reported a successful multi-site validation of its FDA-cleared ECG-AF software, with results published in the journal Heart Rhythm, confirming the tool’s ability to predict one-year atrial fibrillation or flutter risk in over 4,000 patients aged 65 and older. This peer-reviewed evidence strengthens the clinical credibility of Tempus AI’s cardiovascular AI portfolio, highlighting how regulatory-cleared, real-world validated tools could deepen its footprint in...

In recent days, Boot Barn Holdings reported record fiscal 2026 results, with strong same-store sales and rapid store openings drawing praise from analysts and supporting bullish commentary on the business. These developments, reinforced by firm U.S. retail sales data in May, have strengthened investor confidence in Boot Barn’s growth-driven expansion story. Next, we’ll examine how these strong fiscal results and upbeat analyst commentary influence Boot Barn’s existing investment narrative...

On June 15, 2026, Teleflex issued US$500,000,000 of 5.875% senior notes due January 15, 2032, with semi-annual interest payments and detailed redemption, guarantee, and covenant provisions that position the notes as senior unsecured obligations alongside its existing 4.25% senior notes due 2028. This debt raise comes as Teleflex reports revenue ahead of expectations but weaker earnings, highlighting a focus on funding its transformation while managing a relatively fragile financial...

Knife River (KNF) has drawn fresh attention after its earnings estimates improved, alongside outperformance versus the wider Construction sector. This performance has been supported by rising institutional ownership and technical indicators that currently lean toward positive short term momentum. See our latest analysis for Knife River. At a share price of $86.24, Knife River has posted a 7 day share price return of 12.12% and a 30 day share price return of 17.09%. Its 1 year total...

Home BancShares (HOMB) has attracted fresh attention after recent analysis highlighted higher quarterly revenue and net profit, stronger financial health scores within the banking industry, and a rising institutional ownership base. See our latest analysis for Home BancShares. At a share price of $27.65, Home BancShares has seen a 5.86% 90 day share price return and a 3.95% 30 day share price return. The 1 year total shareholder return of 3.09% and 3 year total shareholder return of 36.59%...

Settlement Announcement Puts VNET Group in Focus Pomerantz LLP has announced a proposed class action settlement involving VNET Group (NasdaqGS:VNET), with a US court approving notice to investors who acquired the company’s American Depositary Shares within the specified period. See our latest analysis for VNET Group. The proposed settlement arrives after a period of mixed momentum for VNET Group, with the share price down 11.88% over the past 30 days but a 1 year total shareholder return of...

UMH Properties (UMH) has drawn fresh attention after reporting a first quarter 2026 earnings and revenue beat, announcing a CFO transition, amending its credit facility, and seeing insider share buying by the new finance chief. See our latest analysis for UMH Properties. Against this backdrop, UMH Properties has shown mixed momentum, with the share price up 5.09% over 90 days but down 5.28% year to date. The 3 year total shareholder return of 15.95% contrasts with a 14.57% decline over five...

Precigen (PGEN) is back in focus after the FDA granted orphan drug exclusivity to PAPZIMEOS for adult recurrent respiratory papillomatosis, limiting similar competing therapies for seven years and defining a clearer commercial runway. See our latest analysis for Precigen. The FDA decision comes after a period of strong momentum for Precigen, with the share price delivering a 46.95% 3 month share price return and a very large 1 year total shareholder return. However, the 5 year total...

Johnson & Johnson (JNJ) is back in focus after recent share price weakness, with the stock down 2% over the past month and about 3% over the past 3 months, prompting fresh interest in its valuation. See our latest analysis for Johnson & Johnson. Despite the recent share price weakness over the past week and quarter, Johnson & Johnson’s year to date share price return of 10.15% and 1 year total shareholder return of 56.28% point to momentum that has been positive overall. If this kind of move...